132 related articles for article (PubMed ID: 28216048)
1. Chloroquine blocks the Kir4.1 channels by an open-pore blocking mechanism.
Marmolejo-Murillo LG; Aréchiga-Figueroa IA; Moreno-Galindo EG; Navarro-Polanco RA; Rodríguez-Menchaca AA; Cui M; Sánchez-Chapula JA; Ferrer T
Eur J Pharmacol; 2017 Apr; 800():40-47. PubMed ID: 28216048
[TBL] [Abstract][Full Text] [Related]
2. High-potency block of Kir4.1 channels by pentamidine: Molecular basis.
Aréchiga-Figueroa IA; Marmolejo-Murillo LG; Cui M; Delgado-Ramírez M; van der Heyden MAG; Sánchez-Chapula JA; Rodríguez-Menchaca AA
Eur J Pharmacol; 2017 Nov; 815():56-63. PubMed ID: 28993158
[TBL] [Abstract][Full Text] [Related]
3. The molecular basis of chloroquine block of the inward rectifier Kir2.1 channel.
Rodríguez-Menchaca AA; Navarro-Polanco RA; Ferrer-Villada T; Rupp J; Sachse FB; Tristani-Firouzi M; Sánchez-Chapula JA
Proc Natl Acad Sci U S A; 2008 Jan; 105(4):1364-8. PubMed ID: 18216262
[TBL] [Abstract][Full Text] [Related]
4. Inhibition of Kir4.1 potassium channels by quinacrine.
Marmolejo-Murillo LG; Aréchiga-Figueroa IA; Cui M; Moreno-Galindo EG; Navarro-Polanco RA; Sánchez-Chapula JA; Ferrer T; Rodríguez-Menchaca AA
Brain Res; 2017 May; 1663():87-94. PubMed ID: 28288868
[TBL] [Abstract][Full Text] [Related]
5. The molecular basis of chloroethylclonidine block of inward rectifier (Kir2.1 and Kir4.1) K(+) channels.
Rodríguez-Menchaca AA; Aréchiga-Figueroa IA; Sánchez-Chapula JA
Pharmacol Rep; 2016 Apr; 68(2):383-9. PubMed ID: 26922543
[TBL] [Abstract][Full Text] [Related]
6. Mutational and in silico analyses for antidepressant block of astroglial inward-rectifier Kir4.1 channel.
Furutani K; Ohno Y; Inanobe A; Hibino H; Kurachi Y
Mol Pharmacol; 2009 Jun; 75(6):1287-95. PubMed ID: 19264848
[TBL] [Abstract][Full Text] [Related]
7. Discovery, Characterization, and Effects on Renal Fluid and Electrolyte Excretion of the Kir4.1 Potassium Channel Pore Blocker, VU0134992.
Kharade SV; Kurata H; Bender AM; Blobaum AL; Figueroa EE; Duran A; Kramer M; Days E; Vinson P; Flores D; Satlin LM; Meiler J; Weaver CD; Lindsley CW; Hopkins CR; Denton JS
Mol Pharmacol; 2018 Aug; 94(2):926-937. PubMed ID: 29895592
[TBL] [Abstract][Full Text] [Related]
8. Molecular mechanisms of chloroquine inhibition of heterologously expressed Kir6.2/SUR2A channels.
Ponce-Balbuena D; Rodríguez-Menchaca AA; López-Izquierdo A; Ferrer T; Kurata HT; Nichols CG; Sánchez-Chapula JA
Mol Pharmacol; 2012 Nov; 82(5):803-13. PubMed ID: 22851715
[TBL] [Abstract][Full Text] [Related]
9. Molecular mechanisms of centipede toxin SsTx-4 inhibition of inwardly rectifying potassium channels.
Tang D; Xu J; Li Y; Zhao P; Kong X; Hu H; Liang S; Tang C; Liu Z
J Biol Chem; 2021 Sep; 297(3):101076. PubMed ID: 34391777
[TBL] [Abstract][Full Text] [Related]
10. Regulation of gating by negative charges in the cytoplasmic pore in the Kir2.1 channel.
Xie LH; John SA; Ribalet B; Weiss JN
J Physiol; 2004 Nov; 561(Pt 1):159-68. PubMed ID: 15459242
[TBL] [Abstract][Full Text] [Related]
11. Tamoxifen inhibits inward rectifier K+ 2.x family of inward rectifier channels by interfering with phosphatidylinositol 4,5-bisphosphate-channel interactions.
Ponce-Balbuena D; López-Izquierdo A; Ferrer T; Rodríguez-Menchaca AA; Aréchiga-Figueroa IA; Sánchez-Chapula JA
J Pharmacol Exp Ther; 2009 Nov; 331(2):563-73. PubMed ID: 19654266
[TBL] [Abstract][Full Text] [Related]
12. ML418: The First Selective, Sub-Micromolar Pore Blocker of Kir7.1 Potassium Channels.
Swale DR; Kurata H; Kharade SV; Sheehan J; Raphemot R; Voigtritter KR; Figueroa EE; Meiler J; Blobaum AL; Lindsley CW; Hopkins CR; Denton JS
ACS Chem Neurosci; 2016 Jul; 7(7):1013-23. PubMed ID: 27184474
[TBL] [Abstract][Full Text] [Related]
13. The antimalarial drug mefloquine inhibits cardiac inward rectifier K+ channels: evidence for interference in PIP2-channel interaction.
López-Izquierdo A; Ponce-Balbuena D; Moreno-Galindo EG; Aréchiga-Figueroa IA; Rodríguez-Martínez M; Ferrer T; Rodríguez-Menchaca AA; Sánchez-Chapula JA
J Cardiovasc Pharmacol; 2011 Apr; 57(4):407-15. PubMed ID: 21502926
[TBL] [Abstract][Full Text] [Related]
14. Kir Channel Blockages by Proflavine Derivatives via Multiple Modes of Interaction.
Inanobe A; Itamochi H; Kurachi Y
Mol Pharmacol; 2018 Jun; 93(6):592-600. PubMed ID: 29650538
[TBL] [Abstract][Full Text] [Related]
15. In vitro and in silico characterization of the inhibition of Kir4.1 channels by aminoglycoside antibiotics.
Morán-Zendejas R; Delgado-Ramírez M; Xu J; Valdés-Abadía B; Aréchiga-Figueroa IA; Cui M; Rodríguez-Menchaca AA
Br J Pharmacol; 2020 Oct; 177(19):4548-4560. PubMed ID: 32726456
[TBL] [Abstract][Full Text] [Related]
16. Carvedilol inhibits Kir2.3 channels by interference with PIP₂-channel interaction.
Ferrer T; Ponce-Balbuena D; López-Izquierdo A; Aréchiga-Figueroa IA; de Boer TP; van der Heyden MA; Sánchez-Chapula JA
Eur J Pharmacol; 2011 Oct; 668(1-2):72-7. PubMed ID: 21663737
[TBL] [Abstract][Full Text] [Related]
17. Chloroquine blocks a mutant Kir2.1 channel responsible for short QT syndrome and normalizes repolarization properties in silico.
Lopez-Izquierdo A; Ponce-Balbuena D; Ferrer T; Sachse FB; Tristani-Firouzi M; Sanchez-Chapula JA
Cell Physiol Biochem; 2009; 24(3-4):153-60. PubMed ID: 19710529
[TBL] [Abstract][Full Text] [Related]
18. Inhibition of astroglial inwardly rectifying Kir4.1 channels by a tricyclic antidepressant, nortriptyline.
Su S; Ohno Y; Lossin C; Hibino H; Inanobe A; Kurachi Y
J Pharmacol Exp Ther; 2007 Feb; 320(2):573-80. PubMed ID: 17071817
[TBL] [Abstract][Full Text] [Related]
19. Low-affinity spermine block mediating outward currents through Kir2.1 and Kir2.2 inward rectifier potassium channels.
Ishihara K; Yan DH
J Physiol; 2007 Sep; 583(Pt 3):891-908. PubMed ID: 17640933
[TBL] [Abstract][Full Text] [Related]
20. Propafenone blocks human cardiac Kir2.x channels by decreasing the negative electrostatic charge in the cytoplasmic pore.
Amorós I; Dolz-Gaitón P; Gómez R; Matamoros M; Barana A; de la Fuente MG; Núñez M; Pérez-Hernández M; Moraleda I; Gálvez E; Iriepa I; Tamargo J; Caballero R; Delpón E
Biochem Pharmacol; 2013 Jul; 86(2):267-78. PubMed ID: 23648307
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
